Paracetamol (Acetaminophen) : Pharmakologie und klinische Anwendung.

Der Schmerz
K Menges


No abstract listed.


Apr 19, 1975·Lancet·W S NimmoL F Prescott
Aug 1, 1977·Annals of Internal Medicine·B Ameer, D J Greenblatt
Aug 17, 1977·European Journal of Clinical Pharmacology·S KeinänenK Kouvalainen
Aug 4, 1979·British Medical Journal·N Buchanan, G P Moodley
Oct 1, 1979·Clinical Pharmacology and Therapeutics·G C FarrellL W Powell
Jul 1, 1979·European Journal of Clinical Pharmacology·J A ForrestL F Prescott
May 31, 1978·European Journal of Clinical Pharmacology·A P DouglasM D Rawlins
Jan 1, 1978·Kidney International·E A Molland
Apr 1, 1977·The American Journal of Medicine·J R MitchellS D Nelson
Apr 20, 1977·European Journal of Clinical Pharmacology·M D RawlinsA R Hijab
Jan 1, 1976·The Journal of International Medical Research·G Margetts
Mar 1, 1976·Clinical Pharmacology and Therapeutics·R P MillerL J Fischer
Jan 1, 1986·Drugs·S P Clissold
Dec 1, 1973·The Journal of Pharmacy and Pharmacology·B G GazzardR Williams
Oct 1, 1974·Clinical Pharmacology and Therapeutics·J R MitchellH Keiser
Sep 1, 1974·Journal of Pharmaceutical Sciences·B H ThomasB B Coldwell
Mar 1, 1973·Scottish Medical Journal·N Wrights, L F Prescott
Oct 18, 1971·JAMA : the Journal of the American Medical Association·T D Boyer, S L Rouff
Apr 10, 1971·British Medical Journal·O M EdwardsR T Taylor
Feb 1, 1971·Journal of Pharmaceutical Sciences·G Levy, H Yamada
Aug 27, 1966·British Medical Journal·D G Davidson, W N Eastham
Feb 19, 1982·JAMA : the Journal of the American Medical Association·R W CurryM J Sughrue
Nov 14, 1983·The American Journal of Medicine·U Klotz
Nov 14, 1983·The American Journal of Medicine·A R Temple
Nov 14, 1983·The American Journal of Medicine·R S Nanra
Nov 14, 1983·The American Journal of Medicine·G D Benson
Apr 6, 1984·JAMA : the Journal of the American Medical Association·E M LaskaA Rubin
Oct 1, 1984·Mutation Research·E DybingS D Nelson
Jun 1, 1983·Drugs·A Szczeklik, R J Gryglewski
Jan 2, 1982·British Medical Journal·I CobdenD N Kerr
Jan 1, 1983·Carcinogenesis·A Flaks, B Flaks
Jan 1, 1983·Clinical Pharmacology and Therapeutics·G D Benson
Oct 1, 1980·British Journal of Clinical Pharmacology·L F Prescott
Feb 23, 1981·Archives of Internal Medicine·S A Cooper
Mar 1, 1982·Clinical Pharmacokinetics·J A ForrestL F Prescott
Feb 1, 1982·Clinical Pharmacology and Therapeutics·M DivollD J Greenblatt
Apr 1, 1982·Toxicology and Applied Pharmacology·J V Rutkowski, V H Ferm
Aug 1, 1981·British Journal of Clinical Pharmacology·L F PrescottB Pentland
Feb 23, 1981·Archives of Internal Medicine·A M Rudolph
Jan 14, 1961·Lancet·T W LLOYD

❮ Previous
Next ❯


Jul 1, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·J E ButteryP R Pannall

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.